Genetically programmable pathogen sense and destroy - PubMed (original) (raw)
. 2013 Dec 20;2(12):715-23.
doi: 10.1021/sb4000417. Epub 2013 Jul 2.
Affiliations
- PMID: 23763381
- DOI: 10.1021/sb4000417
Genetically programmable pathogen sense and destroy
Saurabh Gupta et al. ACS Synth Biol. 2013.
Abstract
Pseudomonas aeruginosa (P. aeruginosa) is a major cause of urinary tract and nosocomial infections. Here, we propose and demonstrate proof-of-principle for a potential cell therapy approach against P. aeruginosa. Using principles of synthetic biology, we genetically modified E. coli to specifically detect wild type P. aeruginosa (PAO1) via its quorum sensing (QS) molecule, 3OC 12 HSL. Engineered E. coli sentinels respond to the presence of 3OC 12 HSL by secreting CoPy, a novel pathogen-specific engineered chimeric bacteriocin, into the extracellular medium using the flagellar secretion tag FlgM. Extracellular FlgM-CoPy is designed to kill PAO1 specifically. CoPy was constructed by replacing the receptor and translocase domain of Colicin E3 with that of Pyocin S3. We show that CoPy toxicity is PAO1 specific, not affecting sentinel E. coli or the other bacterial strains tested. In order to define the system's basic requirements and PAO1-killing capabilities, we further determined the growth rates of PAO1 under different conditions and concentrations of purified and secreted FlgM-CoPy. The integrated system was tested by co-culturing PAO1 cells, on semisolid agar plates, together with engineered sentinel E. coli, capable of secreting FlgM-CoPy when induced by 3OC 12 HSL. Optical microscopy results show that the engineered E. coli sentinels successfully inhibit PAO1 growth.
Similar articles
- Construction and characterization of pyocin-colicin chimeric proteins.
Kageyama M, Kobayashi M, Sano Y, Masaki H. Kageyama M, et al. J Bacteriol. 1996 Jan;178(1):103-10. doi: 10.1128/jb.178.1.103-110.1996. J Bacteriol. 1996. PMID: 8550402 Free PMC article. - Identification and functional analysis of a bacteriocin, pyocin S6, with ribonuclease activity from a Pseudomonas aeruginosa cystic fibrosis clinical isolate.
Dingemans J, Ghequire MG, Craggs M, De Mot R, Cornelis P. Dingemans J, et al. Microbiologyopen. 2016 Jun;5(3):413-23. doi: 10.1002/mbo3.339. Epub 2016 Feb 9. Microbiologyopen. 2016. PMID: 26860427 Free PMC article. - Engineering microbes to sense and eradicate Pseudomonas aeruginosa, a human pathogen.
Saeidi N, Wong CK, Lo TM, Nguyen HX, Ling H, Leong SS, Poh CL, Chang MW. Saeidi N, et al. Mol Syst Biol. 2011 Aug 16;7:521. doi: 10.1038/msb.2011.55. Mol Syst Biol. 2011. PMID: 21847113 Free PMC article. - Turning Over a New Leaf: Bacteriocins Going Green.
Ghequire MGK, De Mot R. Ghequire MGK, et al. Trends Microbiol. 2018 Jan;26(1):1-2. doi: 10.1016/j.tim.2017.11.001. Epub 2017 Nov 14. Trends Microbiol. 2018. PMID: 29150081 Review. - Bacteriocins: nature, function and structure.
Daw MA, Falkiner FR. Daw MA, et al. Micron. 1996 Dec;27(6):467-79. doi: 10.1016/s0968-4328(96)00028-5. Micron. 1996. PMID: 9168627 Review.
Cited by
- A bacteriocin expression platform for targeting pathogenic bacterial species.
Rutter JW, Dekker L, Clare C, Slendebroek ZF, Owen KA, McDonald JAK, Nair SP, Fedorec AJH, Barnes CP. Rutter JW, et al. Nat Commun. 2024 Jul 27;15(1):6332. doi: 10.1038/s41467-024-50591-8. Nat Commun. 2024. PMID: 39068147 Free PMC article. - Engineered microorganisms: A new direction in kidney stone prevention and treatment.
Wan W, Wu W, Amier Y, Li X, Yang J, Huang Y, Xun Y, Yu X. Wan W, et al. Synth Syst Biotechnol. 2024 Mar 8;9(2):294-303. doi: 10.1016/j.synbio.2024.02.005. eCollection 2024 Jun. Synth Syst Biotechnol. 2024. PMID: 38510204 Free PMC article. Review. - Advanced probiotics: bioengineering and their therapeutic application.
Parvin T, Sadras SR. Parvin T, et al. Mol Biol Rep. 2024 Feb 25;51(1):361. doi: 10.1007/s11033-024-09309-8. Mol Biol Rep. 2024. PMID: 38403783 Review. - A Bird's-Eye View of the Pathophysiologic Role of the Human Urobiota in Health and Disease: Can We Modulate It?
Jirillo E, Palmirotta R, Colella M, Santacroce L. Jirillo E, et al. Pathophysiology. 2024 Feb 1;31(1):52-67. doi: 10.3390/pathophysiology31010005. Pathophysiology. 2024. PMID: 38390942 Free PMC article. Review. - Novel Genetically Engineered Probiotics for Targeted Elimination of Pseudomonas aeruginosa in Intestinal Colonization.
Kim H, Jang JH, Jung IY, Kim HR, Cho JH. Kim H, et al. Biomedicines. 2023 Sep 27;11(10):2645. doi: 10.3390/biomedicines11102645. Biomedicines. 2023. PMID: 37893018 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical